Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Curran

Showing results (911-920 of 965) with videos related to

Pageof 97
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 20, 2012
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality AssuranceJustin E Bekelman, James A Deye, Bhadrasain Vikram, et al.
Journal of Neuro-Oncology|July 6, 2019
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastomaAndrew B Lassman, Kenneth D Aldape, Peter J Ansell, et al.
JAMA Oncology|March 30, 2023
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical TrialsDian Wang, Jonathan Harris, William G Kraybill, et al.
The New England Journal of Medicine|April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade GliomaJan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2022
An ancient founder mutation located between <i>ROBO1</i> and <i>ROBO2</i> is responsible for increased microtia risk in Amerindigenous populationsDaniel Quiat, Seong Won Kim, Qi Zhang, et al.
Neuro-Oncology|March 5, 2019
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastasesRoshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
Nature Reviews. Clinical Oncology|January 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancerLiora Schultz, Kevin McNerney, Adam J Lamble, et al.
Journal of Neuro-Oncology|November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryMudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2018
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsDaniel W Lee, Bianca D Santomasso, Frederick L Locke, et al.
Pageof 97

Showing results (911-920 of 965) with videos related to

Sort By:
Pageof 97
International Journal of Radiation Oncology, Biology, Physics|March 20, 2012
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality AssuranceJustin E Bekelman, James A Deye, Bhadrasain Vikram, et al.
Journal of Neuro-Oncology|July 6, 2019
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastomaAndrew B Lassman, Kenneth D Aldape, Peter J Ansell, et al.
JAMA Oncology|March 30, 2023
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical TrialsDian Wang, Jonathan Harris, William G Kraybill, et al.
The New England Journal of Medicine|April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade GliomaJan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2022
An ancient founder mutation located between <i>ROBO1</i> and <i>ROBO2</i> is responsible for increased microtia risk in Amerindigenous populationsDaniel Quiat, Seong Won Kim, Qi Zhang, et al.
Neuro-Oncology|March 5, 2019
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastasesRoshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
Nature Reviews. Clinical Oncology|January 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancerLiora Schultz, Kevin McNerney, Adam J Lamble, et al.
Journal of Neuro-Oncology|November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryMudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2018
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsDaniel W Lee, Bianca D Santomasso, Frederick L Locke, et al.
Pageof 97